Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 2, 2006, Pages 153-157

  Kang, Loveleen C ^a,b   Dunphy, Cherie H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CD99 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DNA NUCLEOTIDYLEXOTRANSFERASE; LEUKEMIA ANTIGEN; PARAFFIN; PROTEIN MIC2; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CANCER GRADING; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; EWING SARCOMA; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; LYMPHATIC LEUKEMIA; MONOCYTE; MORPHOLOGY; MYELODYSPLASTIC SYNDROME; NEUROECTODERM TUMOR; PRE B LYMPHOCYTE; T LYMPHOCYTE; THYMOCYTE;

EID: 32544434077     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: 10.5858/2006-130-153-iomcat     Document Type: Article

References (19)

1. Fellinger EJ, Garin-Chesa P, Su SL, DeAngelis P, Lane JM, Rettig WJ. Biochemical and genetic characterization of the HBA.71 Ewing's sarcoma cell surface antigen. Cancer Res. 1991;51:336-340.
2. Gelin C, Aubrit F, Phalipon A, et al. The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product. EMBO J. 1989;8:3253-3259.
3. Hamilton G, Fellinger EJ, Schratter I, Fritsch A. Characterization of a human endocrine tissue and tissue-associated Ewing's sarcoma antigen. Cancer Res. 1988;48:6127-6134.
4. Levy R, Dilley J, Fox RI, Warnke R. A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc Natl Acad Sci U S A. 1979;76:6552-6556.
5. Perlman EJ, Dickman PS, Askin FB, Grier HE, Miser JS, Link MP. Ewing's sarcoma: routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Intergroup study. Hum Pathol. 1994;25:304-307.
6. Chan JKC, Tsang WYW, Seneviratne S, Pau MY. The MIC2 antibody 013: practical application for the study of thymic epithelial tumors. Am J Surg Pathol. 1995;19:1115-1123.
7. Cooper K, Haffajee Z. Immunohistochemical assessment of MIC2 gene product in granulocytic sarcoma using six epitope retrieval systems. Appl Immunohistochem. 1995;3:198-201.
8. MIC2) Immunoreactivity in the diagnosis of thymic neoplasms and mediastinal lymphoproliferative disorders: a study of paraffin sections using monoclonal antibody 013. Appl Immunohistochem. 1996;4:34-42.
9. Ramani P, Rampling D, Link M. Immunocytochemical study of 12E7 in small round-cell tumours of childhood: an assessment of its sensitivity and specificity. Histopathology. 1993;23:557-561.
10. Riopel M, Dickman PS, Link MP, Perlman EJ. MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol. 1994;25:396-399.
11. Soslow RA, Bhargava V, Warnke RA. MIC2, TdT, bcl-2 and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities. Hum Pathol. 1997;28:1158-1165.
12. MIC2) neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical maker. Appl Immunohistochem. 1994;2:231-240.
13. Vartanian RK, Sudilovsky D, Weidner N. Immunostaining of monoclonal antibody 013 [anti-MIC2 gene product (CD99)] in lymphomas: impact of heat-induced epitope retrieval. Appl Immunohistochem. 1996;4:43-55.
14. MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol. 1994;18:486-494.
15. Bodger MP, Francis GE, Delia D, Granger SM, Janossy G. A monoclonal antibody specific for immature human hemopoietic cells and T-lineage cells. J Immunol. 1981;127:2269-2274.
16. Bodger MP, Izaguirre CA, Blacklock HA, Hoffbrand AV. Surface antigenic determinants on human pluripotent and unipotent hematopoietic progenitor cells. Blood. 1983;61:1006-1010.
17. Dworzak MN, Fritsch G, Buchinger P, et al. Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood. Blood. 1994;83:415-425.
18. Robertson PB, Neiman RS, Worapongpaiboon S, John K, Orazi A. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity. Mod Pathol. 1997;10:277-282.
19. Zhang PJ, Barcos M, Stewart CC, Block AW, Sait S, Brooks JJ. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases. Mod Pathol. 2000;13:452-458.